CD45 AND ITS ISOFORMS IN T CELL ACTIVATION
CD45 及其异构体在 T 细胞激活中的作用
基本信息
- 批准号:6373404
- 负责人:
- 金额:$ 26.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-09-30 至 2005-03-31
- 项目状态:已结题
- 来源:
- 关键词:CD antigens T cell receptor T lymphocyte biological signal transduction enzyme activity human subject interleukin 2 laboratory mouse laboratory rabbit leukocyte activation /transformation phosphoprotein phosphatase phosphorylation protein biosynthesis protein isoforms protein tyrosine kinase tissue /cell culture
项目摘要
DESCRIPTION: (Adapted from the Investigator's abstract): The CD45 family of
transmembrane protein tyrosine phosphatases plays a key role in T cell
activation by regulating the activity of Lck and Fyn protein tyrosine kinases.
However, critical aspects of CD45 function remain unresolved. For example, CD45
is composed of multiple isoforms which differ only in their extracellular
domains. These are differentially distributed on subsets of T cells having
distinct functions and activation requirements. While the actual role of the
individual isoforms remains unclear, it has been proposed that the CD45
extracellular domains differentially regulate signaling through the cytoplasmic
domain. This raises the question as to whether CD45 has additional substrates.
Moreover, the role of the two cytoplasmic domains in regulating enzyme activity
and substrate specificity is unclear. Previous difficulties in expressing
different individual CD45 isoforms in the same cell line have been overcome
using a unique model whereby endogenous CD45 expression in the Jurkat human T
cell leukemia line has been specifically blocked by transfection of a
CD45-antisense gene. Such CD45- cells have been reconstituted to uniquely
express either the largest o smallest human CD45 isoform, or various CD45
PTPase mutants. This model has allowed us to demonstrate CD45 isoform-specific
differences in both IL-2 secretion and in the tyrosine phosphorylation of
several key signaling moleules including zeta, ZAP-70, Vav, and SLP-76.
Moreover, transfection of these CD45- cells with CD45 containing specific
PTPase domain mutations (including substrate-trapping versions) has
demonstrated that PTPase Domain 2 is critical for interaction of CD45 with
several novel substrates including the TCR zeta chain, and is required for
phosphorylatia n of ZAP-70. Based on our findings, this application seeks to
provide new understanding of the role of CD45 in T cell activation. This will
include defining the role of CD45 in regulating signaling through these new
substrates and determining the mechanisms by which distinct CD45 isoforms
differentially regulate T cell activation.
In Aim 1 we will define the nature and consequences of the interaction of the
CD45 cytoplasmic domain with these novel substrates. In Aim 2, we will
determine how the expression of distinct CD45 extracellular domains
corresponding to the largest (CD45(ABC ) and smallest (CD45(0)) isoforms
results in altered capacity to produce IL-2; focusing on differential
regulation of proximal events (including PTK activity and zeta phosphorylation)
and Vav and SLP-76, that regulate key pathways involved in activation of the
IL-2 promoter. These studies will provide fundamental knowledge about T cell
activation signaling and growth control. As such, they should ultimately
provide practical insight into hematological malignancie, immune-mediated
diseases, and tolerance.
描述:(改编自研究者的摘要):CD45 家族
跨膜蛋白酪氨酸磷酸酶在T细胞中起关键作用
通过调节 Lck 和 Fyn 蛋白酪氨酸激酶的活性来激活。
然而,CD45 功能的关键方面仍未解决。例如,CD45
由多种亚型组成,仅在细胞外不同
域。这些在具有以下特征的 T 细胞亚群上存在差异性分布:
不同的功能和激活要求。虽然实际作用
个别亚型仍不清楚,有人建议 CD45
细胞外结构域通过细胞质差异调节信号传导
领域。这就提出了 CD45 是否有额外底物的问题。
此外,两个细胞质结构域在调节酶活性中的作用
且底物特异性尚不清楚。以前表达困难
同一细胞系中不同的个体 CD45 同种型已被克服
使用独特的模型,Jurkat 人类 T 中内源性 CD45 表达
细胞白血病系已通过转染特异性阻断
CD45-反义基因。这种 CD45- 细胞已被重组为独特的
表达最大或最小的人类 CD45 同工型,或各种 CD45
PTP酶突变体。该模型使我们能够展示 CD45 亚型特异性
IL-2 分泌和酪氨酸磷酸化的差异
几个关键信号分子,包括 zeta、ZAP-70、Vav 和 SLP-76。
此外,用含有特定CD45的CD45-细胞转染这些CD45-细胞。
PTPase 结构域突变(包括底物捕获版本)
证明 PTPase 结构域 2 对于 CD45 与
几种新颖的底物,包括 TCR zeta 链,并且是
ZAP-70 的磷酸化。根据我们的发现,该应用程序旨在
为 CD45 在 T 细胞激活中的作用提供了新的认识。这将
包括通过这些新的定义 CD45 在调节信号传导中的作用
底物并确定不同 CD45 亚型的机制
差异性调节 T 细胞活化。
在目标 1 中,我们将定义相互作用的性质和后果
CD45 细胞质结构域与这些新底物。在目标 2 中,我们将
确定不同 CD45 胞外结构域的表达方式
对应于最大 (CD45(ABC)) 和最小 (CD45(0)) 同工型
导致产生 IL-2 的能力改变;注重差异化
近端事件的调节(包括 PTK 活性和 zeta 磷酸化)
以及 Vav 和 SLP-76,调节参与激活的关键途径
IL-2启动子。这些研究将提供有关 T 细胞的基础知识
激活信号传导和生长控制。因此,他们最终应该
提供对免疫介导的血液恶性肿瘤的实用见解
疾病和耐受性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID M ROTHSTEIN其他文献
DAVID M ROTHSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID M ROTHSTEIN', 18)}}的其他基金
Role of TIM Molecules in Regulatory and Inflammatory B cells in Allo andAutoimmunity
TIM 分子在同种异体和自身免疫中调节性和炎症性 B 细胞中的作用
- 批准号:
9751742 - 财政年份:2018
- 资助金额:
$ 26.07万 - 项目类别:
Inflammatory B cells defined by TIM-4 in the Alloimmune response
同种免疫反应中 TIM-4 定义的炎症 B 细胞
- 批准号:
10214481 - 财政年份:2018
- 资助金额:
$ 26.07万 - 项目类别:
Immunoregulation by TLR-activated TIM-1+ ProB Cells in Transplantation
TLR 激活的 TIM-1 ProB 细胞在移植中的免疫调节
- 批准号:
10455069 - 财政年份:2018
- 资助金额:
$ 26.07万 - 项目类别:
Role of TIM Molecules in Regulatory and Inflammatory B cells in Allo andAutoimmunity
TIM 分子在同种异体和自身免疫中调节性和炎症性 B 细胞中的作用
- 批准号:
10214475 - 财政年份:2018
- 资助金额:
$ 26.07万 - 项目类别:
Role of TIM Molecules in Regulatory and Inflammatory B cells in Allo andAutoimmunity
TIM 分子在同种异体和自身免疫中调节性和炎症性 B 细胞中的作用
- 批准号:
10455065 - 财政年份:2018
- 资助金额:
$ 26.07万 - 项目类别:
Inflammatory B cells defined by TIM-4 in the Alloimmune response
同种免疫反应中 TIM-4 定义的炎症 B 细胞
- 批准号:
10455071 - 财政年份:2018
- 资助金额:
$ 26.07万 - 项目类别:
Immunoregulation by TLR-activated TIM-1+ ProB Cells in Transplantation
TLR 激活的 TIM-1 ProB 细胞在移植中的免疫调节
- 批准号:
10214480 - 财政年份:2018
- 资助金额:
$ 26.07万 - 项目类别:
Inflammatory B Cells Defined by TIM-4 in the Alloimmune Response
TIM-4 在同种免疫反应中定义的炎症 B 细胞
- 批准号:
9542016 - 财政年份:2017
- 资助金额:
$ 26.07万 - 项目类别:
相似海外基金
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 26.07万 - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 26.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
$ 26.07万 - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
$ 26.07万 - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
$ 26.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
$ 26.07万 - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 26.07万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
$ 26.07万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 26.07万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 26.07万 - 项目类别: